Immuron (IMRN) Gross Profit (2016 - 2024)
Immuron (IMRN) posted quarterly Gross Profit of -$1737594727.2 billion for Q4 2024, down 109950132958505.31% year-over-year from N/an in Q1 2024, and down 109950132958505.31% quarter-over-quarter from $1.6 million in Q4 2023.
Immuron (IMRN) Gross Profit (2016 - 2024) Analysis & Trends
Immuron's Gross Profit history runs 9 years deep, the most recent figure standing at -$1737594727.2 billion for Q4 2024.
- In Q4 2024, Gross Profit fell 109950132958505.31% year-over-year to -$1737594727.2 billion; the TTM figure through Dec 2024 stood at -$1737594727.2 billion (down 83615319075966.94% YoY), while the FY2025 annual figure was $3.1 million, up 41.12% from the prior year.
- Gross Profit for Q4 2024 stood at -$1737594727.2 billion, down from $1.6 million in the prior quarter.
- The five-year high for Gross Profit was $1.6 million in Q4 2023, with the low at -$1737594727.2 billion in Q4 2024.
- The 5-year median for Gross Profit is $37143.9 (2020), against an average of -$289599121.2 billion.
- The sharpest annual moves came in 2022 and 2024: Gross Profit jumped 36086.56% in 2022, then plunged 109950132958505.31% in 2024.
- Immuron's Gross Profit stood at $5656.6 in 2020, then tumbled by 79.09% to $1182.5 in 2021, then surged by 36086.56% to $427920.0 in 2022, then jumped by 269.31% to $1.6 million in 2023, then slumped by 109950132958505.31% to -$1737594727.2 billion in 2024.
- Business Quant data shows IMRN's Gross Profit at -$1737594727.2 billion in Q4 2024, $1.6 million in Q4 2023, and $68631.3 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,737,594,727.21 Bn |
| Dec 31, 2024 | -1,737,594,727.21 Bn |
| Dec 31, 2023 | 1.58 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Jun 30, 2023 | 68,631.26 |
| Jun 30, 2023 | 68,631.26 |
| Dec 31, 2022 | 427,920.00 |
| Dec 31, 2022 | 427,920.00 |
| Dec 31, 2021 | 1,182.54 |
| Dec 31, 2021 | 1,182.54 |
| Dec 31, 2020 | 5,656.57 |
| Dec 31, 2020 | 5,656.57 |
| Dec 31, 2019 | 11,214.25 |
| Dec 31, 2019 | 11,214.25 |
| Dec 31, 2018 | 746,754.00 |
| Dec 31, 2018 | 746,754.00 |
| Dec 31, 2017 | 564,074.12 |
| Dec 31, 2017 | 564,074.12 |
| Dec 31, 2016 | 361,687.03 |
| Dec 31, 2016 | 361,687.03 |